Correlation Between 10X Genomics and Veeva Systems

Can any of the company-specific risk be diversified away by investing in both 10X Genomics and Veeva Systems at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 10X Genomics and Veeva Systems into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between 10X Genomics and Veeva Systems Class, you can compare the effects of market volatilities on 10X Genomics and Veeva Systems and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 10X Genomics with a short position of Veeva Systems. Check out your portfolio center. Please also check ongoing floating volatility patterns of 10X Genomics and Veeva Systems.

Diversification Opportunities for 10X Genomics and Veeva Systems

-0.49

Correlation Coefficient

10X Genomics  Veeva Systems

Very good diversification

The 3 months correlation between 10X and Veeva is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding 10X Genomics and Veeva Systems Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Veeva Systems Class and 10X Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 10X Genomics are associated (or correlated) with Veeva Systems. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Veeva Systems Class has no effect on the direction of 10X Genomics i.e., 10X Genomics and Veeva Systems go up and down completely randomly.

Pair Corralation between 10X Genomics and Veeva Systems

Considering the 90-day investment horizon 10X Genomics is expected to under-perform the Veeva Systems. In addition to that, 10X Genomics is 2.28 times more volatile than Veeva Systems Class. It trades about -0.14 of its total potential returns per unit of risk. Veeva Systems Class is currently generating about 0.09 per unit of volatility. If you would invest  21,401  in Veeva Systems Class on December 27, 2024 and sell it today you would earn a total of  2,160  from holding Veeva Systems Class or generate 10.09% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

10X Genomics  vs.  Veeva Systems Class

10X Genomics

Risk-Adjusted Performance

Very Weak

Over the last 90 days 10X Genomics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Veeva Systems Class

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Veeva Systems Class are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak technical and fundamental indicators, Veeva Systems may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with 10X Genomics and Veeva Systems

The main advantage of trading using opposite 10X Genomics and Veeva Systems positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 10X Genomics position performs unexpectedly, Veeva Systems can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Veeva Systems will offset losses from the drop in Veeva Systems' long position.

The idea behind 10X Genomics and Veeva Systems Class pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.